A revolutionary technique that promises to restore the sight of millions has been carried out for the first time worldwide in a British hospital.
Taking as little as 45 minutes, the procedure offers hope to those with age-related macular degeneration, the leading cause of blindness in adults globally.
It affects more than 600,000 adults in the UK, blighting the lives of a quarter of the over-60s.
In the breakthrough developed at University College London, doctors inserted a patch of stem cells into the retina of a woman who has lost her central vision.
They hope the procedure, carried out at Moorfields Eye Hospital in the capital, will restore the 60-year-old’s sight but will not know the outcome until December.
However, doctors said she suffered no complications and her eye is recovering well from the procedure.
This first operation has begun a clinical trial involving ten patients. If successful, the technique could be available on the NHS within two-and-a-half years.
The procedure, which has attracted the support of medical giant Pfizer, is carried out under local anaesthetic. It involves taking a single embryonic stem cell and growing it into a 6mm patch of 100,000 retinal pigment cells.
That patch is then rolled into a thin tube, which is injected through a tiny slit in the eye.
Once unfurled, it is placed behind the retina where scientists hope it will replace the faulty cells.
The operation is a milestone in the London Project to Cure Blindness established ten years ago with the aim of curing vision loss in patients with age-related macular degeneration.
The first step has been carried out on the wet form of the condition when a patient bleeds at the back of the eye. But scientists are confident it could also be used for the more common dry AMD, which affects 85 per cent of British sufferers.
The Latest on: Age-related macular degeneration
[google_news title=”” keyword=”age-related macular degeneration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Age-related macular degeneration
- Age-related macular degeneration confers greater risk of COVID-19 infection and mortalityon January 8, 2023 at 6:30 am
USA: Findings from a new study, published in Journal of Clinical Medicine, adds to the body of evidence that patients with age-related macular degeneration (AMD) may be at increased risk of infection ...
- Update on Combination Therapy in Wet Age-related Macular Degenerationon January 5, 2023 at 4:00 pm
Age-related macular degeneration is the most common cause of choroidal neovascularization (CNV) and it is an important cause of vision loss in the ageing population. CNV is a multifactorial ...
- Neovascular Age-Related Macular Degenerationon January 5, 2023 at 4:00 pm
Choroidal neovascularization is the primary cause of visual loss in patients with age-related macular degeneration. Current treatments, proven to offer a benefit for these patients through ...
- Age Related Macular Degeneration Drug Market Size in 2023 [ New Report ] Global Survey with Forecast 2028 & Comprehensive Analysis in Reporton January 4, 2023 at 10:57 am
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for â straight-aheadâ activities such as reading, sewing, and driving. AMD affects the ...
- Age-related Macular Degeneration Increases Risk of Severe COVID-19 Infectionon January 4, 2023 at 7:23 am
Age-related macular degeneration is an eye condition that can have serious consequences among COVID-19 individuals It increases the risk of severe complications such as respiratory failure and death ...
- People With Age-Related Macular Degeneration More Prone To Severe COVID-19: Know Whyon January 3, 2023 at 8:29 pm
COVID-19 infections can be dangerous for people with age-related macular degeneration (AMD), an eye disease that can affect the central vision, as well. Caused by damage to the macula (a part of ...
- Age-related macular degeneration a risk factor for COVID-19 infection, severe diseaseon January 3, 2023 at 8:25 pm
Researchers hypothesized that AMD and COVID-19 share common genetic risk factors and carried out a study that identified a novel association of the two diseases with variants in the PDGFB gene.
- Age-Related Macular Degeneration a Risk Factor for COVID-19 Infection and Severe Diseaseon January 3, 2023 at 3:03 pm
More severe COVID-19 outcomes associated with age-related macular degeneration likely arise from a genetic predisposition in addition to higher levels of Pdgf in blood serum.
- Age-related macular degeneration a risk factor for COVID-19 infection, severe diseaseon January 2, 2023 at 4:00 pm
Recent evidence has emerged to suggest that age-related macular degeneration (AMD) is a clinical risk factor for increased risk for infection and mortality. AMD has been reported to confer higher ...
- Haims: The two types of age-related macular degenerationon December 12, 2022 at 1:48 pm
I recently spoke to Dr. Jonathan Owens at Rocky Mountain Vision about a specific diagnosis of macular degeneration called age-related macular degeneration. He was happy to share his knowledge with me ...
via Bing News